DrugCard

AI-assisted medical literature monitoring platform for pharmacovigilance literature screening and case intake.

DrugCard, founded in 2019 and registered in Tallinn, Estonia, provides a literature-monitoring platform for pharmacovigilance teams. It screens local and global medical literature — including non-English local journals — for adverse reaction mentions, using automated translation and AI-assisted screening to surface potential individual case safety reports for human review. The company reports hosting on ISO/IEC 27001- and SOC 2-certified AWS infrastructure; Atlas does not treat inherited infrastructure certifications as vendor-held certifications.

Headquarters
Tallinn, Estonia
Founded
2019
Deployment options
cloud
Website
https://drug-card.io
LinkedIn
https://www.linkedin.com/company/drugcards

Categories

AI Use Cases

  • Case Processing Automation

Vendor Scorecard

50% — Partial coverage. Coverage score — how completely Atlas documents DrugCard across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.

Compliance & Validation — Not documented by Atlas

Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?

Deployment & Hosting — Documented

cloud

Pricing Transparency — Not documented by Atlas

Ask the vendor: What is your pricing model, and what drives total cost of ownership?

Implementation & Onboarding — Not documented by Atlas

Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?

Organization & Role Fit — Documented

Biotech Startup, Mid-Size Biotech, CRO / CDMO, Pharmacovigilance

Solution Scope — Documented

Adverse Event Detection, Natural Language Processing

Company Viability — Partially documented

Private, Founded 2019

Always ask the vendor

Not captured in Atlas data — confirm directly. Excluded from the score above.

Data Rights & IP

Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?

Model Credibility & Explainability

Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?

Questions to Ask This Vendor

  • Which local-language journals and sources are covered for our territories?
  • How is screening recall measured, and what does the human review workflow look like?
  • What audit trail is available for literature screening decisions?
  • What certifications does the company itself hold, versus its hosting provider?